Skip to content
  • Home
  • Signal News
  • Biopharma Digest
    • Market Access Intelligence
    • Rare Disease Gene Therapy
    • Oncology
  • Week in Review
    • GLP-1 Competitive Market
    • NeuroMarket Pulse
      • Neurology Regulatory Interactive Calendar
    • Manufacturing Intelligence
  • Contact

Pharminent

 Posted in Policy / Pricing

A ‘hijacked plane’: CDC, under RFK Jr.’s influence, trades science for dogma

 April 1, 2026

BioPharma Dive

A series of controversial policy changes directed by the HHS secretary have left experts fearful of the future implications for public health.

Policy / PricingRead full story

Post navigation

Agios mulls early FDA filing for sickle cell therapy →
← FDA, after turbulent year, leaves drugmakers guessing on its direction

Categories

© 2026 Pharminent. All rights reserved.

Design by ThemesDNA.com